Pentoxifylline and Endometriosis

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy...

Date First Received: March 4, 2008

Last Updated: March 10, 2008

Verified by: Hospital Clinic of Barcelona, March 2008

Clinical Trial Phase: Phase 3 | Start Date: October 2001

Overall Status: Completed

Estimated Enrollment: 104

Brief Summary

Official Title: “Combined Laparoscopic Surgery and Pentoxifylline Therapy for Treatment of Endometriosis-Associated Infertility: A Preliminary Study”

Condition Keyword(s):

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy surgery

Study Type: Interventional

Study Design: Treatment, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Efficacy Study

Study Primary Completion Date: December 2006

Intervention(s) in this Clinical Trial

  • Drug: pentoxifylline
    • 800 mg daily for six months
  • Drug: placebo

Arms, Groups and Cohorts in this Clinical Trial

  • Active Comparator: 1
  • Placebo Comparator: 2

Outcome Measures for this Clinical Trial

Primary Measures

  • Pregnancy rate
    • Time Frame: 6 months follow-up
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Infertile patients having early endometriosis as the only factor of their infertility

Exclusion Criteria:

  • Previous treatment for endometriosis or patients having pelvic disorders in addition to endometriosis

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 40 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Hospital Clinic of Barcelona

Additional Information

Information obtained from ClinicalTrials.gov on August 29, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00632697

Study ID Number: LETS

ClinicalTrials.gov Identifier: NCT00632697

Health Authority: Spain: Comité Ético de Investigación Clínica

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.